Chun-Wan received her Bachelor's degree from the Chemistry Department at National Taiwan University. She came to the USA for her Ph.D. degree from the Chemistry Department at Georgia Institute of Technology. After her Ph.D., she received the ORISE fellowship and started her postdoctoral training at the Massachusetts Institute of Technology. She started her industrial career at Merck Research Laboratory in 2015-2018. Currently, she is a Principal Scientist in the preformulation group at Genentech, and her pipeline support includes preclinical formulation development for the various dosing routes. She is interested in drug delivery for exotic modalities, including oligonucleotides, peptides, and mRNAs to support undruggable targets. Chun-Wan has published 20+ peer-review papers and two patents.